Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

Journal Article

2014

Permanent link to this Item
http://hdl.handle.net/11427/14992
 http://dx.doi.org/10.1371/journal.pmed.1001718
Files
Boulle_Mortality_in_Patients_2014.pdf (779.12 KB)
Authors
Boulle, Andrew
Schomaker, Michael
May, Margaret T
Hogg, Robert S
Shepherd, Bryan E
Monge, Susana
Keiser, Olivia
Lampe, Fiona C
Giddy, Janet
Ndirangu, James
Journal Title

PLOS Medicince

Link to Journal
http://journals.plos.org/plosmedicine
Journal ISSN
Volume Title
Publisher

Public Library of Science

Publisher

University of Cape Town

Department
Institute of Infectious Disease and Molecular Medicine
Faculty
Faculty of Health Sciences
License

http://creativecommons.org/licenses/by/4.0

Series
Abstract
Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary
Description
Keywords
Death rates
North America
Europe
South Africa
Antiretroviral therapy
HIV
AIDS
Viral load

Reference:

Boulle, A., Schomaker, M., May, M. T., Hogg, R. S., Shepherd, B. E., Monge, S., ... & Sterne, J. A. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS medicine, 11(9), e1001718. doi:10.1371/journal.pmed.1001718

Collections
Journal Articles